NCT00272831View on ClinicalTrials.gov

The Use of Cilostazol in Patients With Diabetic Nephropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Diabetes Mellitus, Type 2Diabetes Complications
Interventions
DRUG

Cilostazol

Cilostazol 100 mg twice daily

DRUG

Placebo

1 tablet twice daily

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00272831 - The Use of Cilostazol in Patients With Diabetic Nephropathy | Biotech Hunter | Biotech Hunter